In 2016, an estimated 70 580 people in the USA will have been diagnosed and 20 150 will have died from non-Hodgkin lymphoma (NHL).¹ NHL incidence rates increased over the latter half of the 20th century and only recently stabilized. In parallel, NHL survival rates began improving in the 1990 s with the advent of improved treatment strategies, leading to the current 5-year survival rate of 72%.² These trends have led to a growth in the number of NHL survivors, estimated at over 630 000 in the USA in 2013.³

中文翻译：

---

队列简介：淋巴瘤专业卓越研究计划 (SPORE) 分子流行病学资源 (MER) 队列研究


2016 年，美国估计将有 70,580 人被诊断出患有非霍奇金淋巴瘤 (NHL)，其中 20,150 人将死于非霍奇金淋巴瘤。 ¹ NHL 发病率在 20 世纪下半叶有所上升，直到最近才趋于稳定。与此同时，随着治疗策略的改进，NHL 的生存率在 20 世纪 90 年代开始提高，目前的 5 年生存率为 72%。 ²这些趋势导致 NHL 幸存者人数增加，2013 年美国估计超过 630 000 人。 ³